DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748404. A total of 13 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trexquant Investment LP | 10,631 | $71,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 16,565 | $109,000 | 0.00% |
| VANGUARD GROUP INC | 79,970 | $534,000 | 0.00% |
| UBS Group AG | 430 | $3,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 10 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 600 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 126 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,165 | $112,000 | 0.00% |
| CREDIT SUISSE AG/ | 79 | $1,000 | 0.00% |